Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Fadi Braiteh, MD

Dr. Braiteh
Las Vegas, NV

Dr. Fadi Braiteh

Medical Oncologist

Comprehensive Cancer Centers of Nevada

Central Valley Treatment Center
3730 South Eastern Avenue
Las Vegas, NV 89169

Need Help Contacting This Doctor?

Dr. Fadi Braiteh is currently a medical oncologist at the Comprehensive Cancer Centers of Nevada (CCCN), located in Las Vegas, Nevada. Prior to his position at CCCN, Dr. Brataih was a medical oncologist and Director of the Phase I Program and Drug Development Center at the Cancer and Hematology Centers of Western Michigan. There, he also held positions as Clinical Assistant Professor of Medicine at Michigan State University's School of Human Medicine and scientific investigator for the Program of Translational Medicine and Phase I Clinical Trials at Van Andrel Research Institute.

Dr. Braiteh has coninuted his studies through clinical research, studying aspects of cancer treatment like the use of biomarkers, palliative medicine, immunotherapy and much more. As a result, he has been published in over 80 peer-reviewed articles and won numerous awards for his research and training successes.

Main Specialty: Medical Oncology

Other Interests & Specialties: Gastrointestinal malignancies, lung cancer, breast cancer, immuno-oncology and phase I clinical trials.

Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Hospice and Palliative Medicine, American Board of Internal Medicine Certification in Medical Oncology, Healthcare Headliner in Medical Research Award, The 1% Top Researcher Club by US Oncology Research Network Award, named one of America’s Top Oncologists by Castle-Connolly, Everyday Heroes Award from the American Red Cross, Susan G. Komen Scholar-In-Training Award

Education & Experience:

Oral MEK1/MEK2 inhibitor trametinib (GSK1120212) in combination with docetaxel in KRAS-mutant and wild-type (WT) advanced non-small cell lung cancer (NSCLC): A phase I/Ib trial. Journal of Clinical Oncology. January 2017;31(15):8028.

CD30 expression in nonlymphomatous malignancies. Journal of Clinical Oncology. January 2017;30(15):3069

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide